Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Membrane Transport Proteins | 6 | 2016 | 175 | 2.260 |
Why?
|
| Bacterial Proteins | 10 | 2020 | 890 | 2.120 |
Why?
|
| Stearoyl-CoA Desaturase | 3 | 2023 | 9 | 2.020 |
Why?
|
| Models, Molecular | 22 | 2021 | 1079 | 1.990 |
Why?
|
| Cryoelectron Microscopy | 6 | 2024 | 214 | 1.850 |
Why?
|
| Iron | 7 | 2023 | 270 | 1.850 |
Why?
|
| Potassium Channels | 7 | 2020 | 157 | 1.730 |
Why?
|
| Copper Radioisotopes | 4 | 2018 | 6 | 1.280 |
Why?
|
| Crystallography, X-Ray | 15 | 2020 | 357 | 1.240 |
Why?
|
| Metal Nanoparticles | 3 | 2018 | 42 | 1.100 |
Why?
|
| Sulfides | 3 | 2015 | 21 | 1.100 |
Why?
|
| Cation Transport Proteins | 3 | 2023 | 93 | 1.060 |
Why?
|
| Protein Structure, Tertiary | 6 | 2015 | 767 | 1.050 |
Why?
|
| Electrons | 2 | 2023 | 24 | 1.020 |
Why?
|
| Shaker Superfamily of Potassium Channels | 4 | 2012 | 31 | 1.020 |
Why?
|
| Binding Sites | 11 | 2023 | 1303 | 1.000 |
Why?
|
| Copper | 5 | 2018 | 64 | 0.990 |
Why?
|
| Low-Level Light Therapy | 2 | 2016 | 15 | 0.980 |
Why?
|
| Protein Conformation | 10 | 2020 | 834 | 0.880 |
Why?
|
| Ion Channel Gating | 6 | 2014 | 122 | 0.880 |
Why?
|
| Cations, Divalent | 1 | 2023 | 20 | 0.850 |
Why?
|
| Diacylglycerol Cholinephosphotransferase | 1 | 2023 | 3 | 0.850 |
Why?
|
| Biocatalysis | 1 | 2023 | 34 | 0.850 |
Why?
|
| Nanoparticles | 3 | 2020 | 232 | 0.840 |
Why?
|
| Eukaryotic Cells | 1 | 2023 | 32 | 0.840 |
Why?
|
| Cytochromes b5 | 2 | 2020 | 3 | 0.820 |
Why?
|
| Cytochromes b | 1 | 2022 | 5 | 0.810 |
Why?
|
| Oxidoreductases | 4 | 2023 | 92 | 0.780 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2024 | 143 | 0.780 |
Why?
|
| Hepcidins | 2 | 2023 | 19 | 0.760 |
Why?
|
| Symporters | 1 | 2022 | 69 | 0.750 |
Why?
|
| Anion Transport Proteins | 1 | 2021 | 30 | 0.730 |
Why?
|
| Cell Membrane | 4 | 2016 | 462 | 0.730 |
Why?
|
| Arabidopsis Proteins | 1 | 2021 | 40 | 0.720 |
Why?
|
| Cortisone | 2 | 2012 | 10 | 0.710 |
Why?
|
| Arabidopsis | 1 | 2021 | 71 | 0.700 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2020 | 190 | 0.700 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2020 | 4 | 0.690 |
Why?
|
| Glucose | 2 | 2016 | 877 | 0.690 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2020 | 5 | 0.690 |
Why?
|
| Protein Binding | 8 | 2020 | 1756 | 0.690 |
Why?
|
| Animals | 27 | 2024 | 34232 | 0.670 |
Why?
|
| Membrane Potentials | 3 | 2020 | 306 | 0.660 |
Why?
|
| Vibrio parahaemolyticus | 3 | 2020 | 7 | 0.640 |
Why?
|
| Escherichia coli Proteins | 2 | 2020 | 304 | 0.630 |
Why?
|
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2018 | 5 | 0.600 |
Why?
|
| Biological Transport | 4 | 2022 | 356 | 0.590 |
Why?
|
| Urea | 3 | 2014 | 231 | 0.580 |
Why?
|
| Heme | 2 | 2023 | 52 | 0.570 |
Why?
|
| Positron-Emission Tomography | 2 | 2016 | 306 | 0.550 |
Why?
|
| Mammals | 3 | 2023 | 257 | 0.550 |
Why?
|
| Liposomes | 2 | 2015 | 188 | 0.540 |
Why?
|
| Coordination Complexes | 1 | 2016 | 6 | 0.540 |
Why?
|
| Laser Therapy | 2 | 2018 | 249 | 0.520 |
Why?
|
| Thermography | 1 | 2016 | 11 | 0.520 |
Why?
|
| Structure-Activity Relationship | 5 | 2020 | 581 | 0.520 |
Why?
|
| Bacillus cereus | 2 | 2018 | 8 | 0.520 |
Why?
|
| Ovarian Neoplasms | 2 | 2020 | 419 | 0.520 |
Why?
|
| Metals | 1 | 2016 | 63 | 0.510 |
Why?
|
| Oxygen | 2 | 2016 | 556 | 0.510 |
Why?
|
| Combined Modality Therapy | 3 | 2020 | 1242 | 0.490 |
Why?
|
| Antigens, Neoplasm | 2 | 2023 | 385 | 0.490 |
Why?
|
| NADP | 3 | 2023 | 53 | 0.490 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2015 | 25 | 0.480 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 1 | 2015 | 16 | 0.480 |
Why?
|
| Protein Multimerization | 3 | 2021 | 128 | 0.470 |
Why?
|
| Kidney | 3 | 2012 | 1368 | 0.470 |
Why?
|
| Dimethylallyltranstransferase | 1 | 2014 | 4 | 0.460 |
Why?
|
| Escherichia coli | 1 | 2020 | 985 | 0.450 |
Why?
|
| Potassium | 3 | 2020 | 282 | 0.440 |
Why?
|
| Yersinia | 1 | 2013 | 5 | 0.440 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2015 | 211 | 0.440 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 128 | 0.430 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 2513 | 0.410 |
Why?
|
| Thyroid Neoplasms | 1 | 2015 | 189 | 0.400 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2014 | 130 | 0.400 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 558 | 0.390 |
Why?
|
| Ion Transport | 3 | 2020 | 52 | 0.370 |
Why?
|
| Kv1.1 Potassium Channel | 2 | 2011 | 36 | 0.370 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 411 | 0.370 |
Why?
|
| Aldehyde Reductase | 2 | 2008 | 17 | 0.360 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 541 | 0.350 |
Why?
|
| Substrate Specificity | 4 | 2016 | 295 | 0.340 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 140 | 0.340 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 320 | 0.340 |
Why?
|
| Desulfovibrio vulgaris | 1 | 2009 | 1 | 0.340 |
Why?
|
| Mice, Nude | 3 | 2016 | 708 | 0.330 |
Why?
|
| Electron Transport | 2 | 2022 | 55 | 0.320 |
Why?
|
| Amino Acid Sequence | 5 | 2014 | 2714 | 0.320 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2008 | 12 | 0.310 |
Why?
|
| Static Electricity | 2 | 2021 | 45 | 0.300 |
Why?
|
| Carrier Proteins | 1 | 2013 | 1022 | 0.300 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 2006 | 59 | 0.290 |
Why?
|
| Acyl Coenzyme A | 2 | 2020 | 25 | 0.290 |
Why?
|
| Molecular Conformation | 2 | 2022 | 106 | 0.290 |
Why?
|
| Protein Structure, Quaternary | 4 | 2013 | 98 | 0.290 |
Why?
|
| Hyperthermia, Induced | 3 | 2016 | 54 | 0.280 |
Why?
|
| Mice | 9 | 2020 | 17631 | 0.280 |
Why?
|
| Protein Domains | 2 | 2020 | 236 | 0.280 |
Why?
|
| Oxidation-Reduction | 3 | 2016 | 443 | 0.270 |
Why?
|
| Catalytic Domain | 2 | 2020 | 158 | 0.270 |
Why?
|
| Adenosine Diphosphate | 2 | 2020 | 58 | 0.270 |
Why?
|
| Phosphorylation | 3 | 2018 | 1631 | 0.260 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2006 | 20 | 0.260 |
Why?
|
| HEK293 Cells | 3 | 2020 | 733 | 0.260 |
Why?
|
| Humans | 23 | 2024 | 125189 | 0.250 |
Why?
|
| Adenosine Triphosphate | 2 | 2020 | 282 | 0.250 |
Why?
|
| Xenopus laevis | 3 | 2012 | 127 | 0.250 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 1659 | 0.250 |
Why?
|
| Phototherapy | 2 | 2015 | 34 | 0.240 |
Why?
|
| Cell Line, Tumor | 4 | 2016 | 3348 | 0.240 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2018 | 104 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3573 | 0.230 |
Why?
|
| Recombinant Proteins | 3 | 2021 | 1399 | 0.230 |
Why?
|
| Ions | 1 | 2004 | 22 | 0.230 |
Why?
|
| Halogens | 1 | 2024 | 2 | 0.220 |
Why?
|
| Molecular Sequence Data | 4 | 2014 | 3892 | 0.220 |
Why?
|
| Bicarbonates | 1 | 2024 | 98 | 0.220 |
Why?
|
| Carbohydrate Metabolism | 2 | 2016 | 57 | 0.220 |
Why?
|
| Rats | 6 | 2016 | 3727 | 0.220 |
Why?
|
| Chlorides | 1 | 2024 | 107 | 0.210 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2023 | 6 | 0.210 |
Why?
|
| Phosphatidylcholines | 1 | 2023 | 37 | 0.210 |
Why?
|
| Phosphotransferases | 1 | 2023 | 40 | 0.210 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2014 | 658 | 0.210 |
Why?
|
| Catalysis | 1 | 2023 | 127 | 0.210 |
Why?
|
| Hemochromatosis | 1 | 2023 | 33 | 0.200 |
Why?
|
| Receptors, Cholinergic | 2 | 2000 | 84 | 0.200 |
Why?
|
| Peptide Transporter 1 | 1 | 2022 | 1 | 0.200 |
Why?
|
| Oocytes | 4 | 2009 | 298 | 0.200 |
Why?
|
| Xenopus | 4 | 2008 | 111 | 0.200 |
Why?
|
| Horses | 1 | 2022 | 90 | 0.190 |
Why?
|
| Mutagenesis | 2 | 2020 | 345 | 0.190 |
Why?
|
| Sulfates | 1 | 2021 | 35 | 0.190 |
Why?
|
| Amines | 1 | 2001 | 36 | 0.180 |
Why?
|
| Potassium Channel Blockers | 1 | 2001 | 84 | 0.180 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2018 | 78 | 0.180 |
Why?
|
| Prostate | 1 | 2023 | 435 | 0.180 |
Why?
|
| Fatty Acids | 1 | 2023 | 344 | 0.180 |
Why?
|
| Protein Folding | 2 | 2013 | 215 | 0.170 |
Why?
|
| Molecular Structure | 2 | 2014 | 295 | 0.170 |
Why?
|
| Sf9 Cells | 1 | 2020 | 9 | 0.170 |
Why?
|
| Lipid Metabolism | 1 | 2023 | 357 | 0.170 |
Why?
|
| Polyethylene Glycols | 3 | 2018 | 229 | 0.170 |
Why?
|
| Diglycerides | 1 | 2020 | 18 | 0.170 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 426 | 0.170 |
Why?
|
| Patch-Clamp Techniques | 4 | 2008 | 282 | 0.170 |
Why?
|
| Glutamic Acid | 1 | 2021 | 203 | 0.170 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 897 | 0.170 |
Why?
|
| Swine | 1 | 2024 | 1210 | 0.170 |
Why?
|
| Kinetics | 2 | 2016 | 1333 | 0.170 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2020 | 20 | 0.170 |
Why?
|
| Melanoma, Experimental | 1 | 2020 | 35 | 0.170 |
Why?
|
| X-Ray Diffraction | 1 | 2020 | 96 | 0.170 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2020 | 52 | 0.170 |
Why?
|
| Zinc | 1 | 2020 | 135 | 0.160 |
Why?
|
| Peptides | 2 | 2022 | 811 | 0.160 |
Why?
|
| Choline | 1 | 1999 | 54 | 0.160 |
Why?
|
| Myasthenia Gravis | 1 | 1999 | 73 | 0.160 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2018 | 18 | 0.150 |
Why?
|
| Electrophysiology | 2 | 2011 | 271 | 0.150 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 128 | 0.150 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2020 | 136 | 0.150 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2018 | 64 | 0.150 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 211 | 0.140 |
Why?
|
| Calcium | 1 | 2023 | 1102 | 0.140 |
Why?
|
| Sequence Deletion | 1 | 2020 | 525 | 0.140 |
Why?
|
| Cysteine | 1 | 2018 | 139 | 0.140 |
Why?
|
| Triglycerides | 1 | 2020 | 575 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 2891 | 0.140 |
Why?
|
| Biochemical Phenomena | 1 | 2016 | 3 | 0.140 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2016 | 22 | 0.140 |
Why?
|
| Cell Line | 4 | 2016 | 2756 | 0.140 |
Why?
|
| Biophysical Phenomena | 1 | 2016 | 39 | 0.130 |
Why?
|
| Circular Dichroism | 1 | 2016 | 86 | 0.130 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2016 | 23 | 0.130 |
Why?
|
| Gold | 1 | 2016 | 48 | 0.130 |
Why?
|
| Melanoma | 1 | 2023 | 942 | 0.130 |
Why?
|
| Drug Carriers | 1 | 2016 | 100 | 0.120 |
Why?
|
| Rabbits | 1 | 2016 | 718 | 0.120 |
Why?
|
| Radiopharmaceuticals | 1 | 2016 | 168 | 0.120 |
Why?
|
| Syk Kinase | 1 | 2015 | 16 | 0.120 |
Why?
|
| Histidine | 1 | 2015 | 73 | 0.120 |
Why?
|
| Multimodal Imaging | 1 | 2016 | 114 | 0.120 |
Why?
|
| Radiotherapy | 1 | 2015 | 135 | 0.120 |
Why?
|
| Doxorubicin | 1 | 2016 | 290 | 0.120 |
Why?
|
| Protein Transport | 1 | 2016 | 368 | 0.120 |
Why?
|
| Photoacoustic Techniques | 1 | 2014 | 9 | 0.120 |
Why?
|
| Archaeoglobus fulgidus | 1 | 2014 | 2 | 0.120 |
Why?
|
| Thyroid Gland | 1 | 2015 | 104 | 0.110 |
Why?
|
| Magnesium | 1 | 2014 | 123 | 0.110 |
Why?
|
| Rotation | 1 | 2013 | 51 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2015 | 294 | 0.110 |
Why?
|
| Electric Conductivity | 1 | 2013 | 87 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 686 | 0.100 |
Why?
|
| Precision Medicine | 1 | 2016 | 319 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 889 | 0.100 |
Why?
|
| Fluticasone | 1 | 2012 | 15 | 0.100 |
Why?
|
| Osmosis | 1 | 2012 | 16 | 0.100 |
Why?
|
| Sodium | 1 | 2013 | 297 | 0.100 |
Why?
|
| Androstadienes | 1 | 2012 | 50 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 997 | 0.100 |
Why?
|
| Metabolism | 1 | 2012 | 42 | 0.100 |
Why?
|
| Bile Acids and Salts | 1 | 2013 | 244 | 0.090 |
Why?
|
| Drug Design | 1 | 2012 | 152 | 0.090 |
Why?
|
| Crystallization | 1 | 2011 | 83 | 0.090 |
Why?
|
| Cattle | 1 | 2012 | 568 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 127 | 0.090 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2011 | 88 | 0.090 |
Why?
|
| Contrast Media | 1 | 2014 | 480 | 0.090 |
Why?
|
| Ligands | 1 | 2012 | 539 | 0.090 |
Why?
|
| Mutation | 3 | 2004 | 5845 | 0.090 |
Why?
|
| DNA Primers | 1 | 2011 | 657 | 0.080 |
Why?
|
| Algorithms | 1 | 2016 | 1629 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 2057 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2009 | 165 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1020 | 0.080 |
Why?
|
| Binding, Competitive | 1 | 2008 | 192 | 0.080 |
Why?
|
| Streptomyces lividans | 1 | 2007 | 1 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 930 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 112 | 0.070 |
Why?
|
| Cations | 1 | 2007 | 39 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 1586 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2011 | 940 | 0.070 |
Why?
|
| Female | 5 | 2020 | 66806 | 0.070 |
Why?
|
| Proteins | 1 | 2012 | 1036 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2008 | 627 | 0.070 |
Why?
|
| Aldo-Keto Reductases | 1 | 2006 | 2 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 1314 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 1755 | 0.060 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 209 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2008 | 789 | 0.060 |
Why?
|
| Rubidium | 1 | 2004 | 5 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 983 | 0.060 |
Why?
|
| Ipilimumab | 1 | 2023 | 62 | 0.050 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2001 | 30 | 0.050 |
Why?
|
| Point Mutation | 2 | 2000 | 348 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2001 | 620 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12392 | 0.040 |
Why?
|
| Peptides, Cyclic | 1 | 2018 | 55 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 703 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 4395 | 0.040 |
Why?
|
| Transfection | 1 | 1999 | 1069 | 0.030 |
Why?
|
| Male | 3 | 2023 | 61525 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2020 | 372 | 0.030 |
Why?
|
| Syndrome | 1 | 1999 | 1121 | 0.030 |
Why?
|
| Ethiodized Oil | 1 | 2016 | 3 | 0.030 |
Why?
|
| Nanospheres | 1 | 2016 | 7 | 0.030 |
Why?
|
| Metabolomics | 1 | 2020 | 423 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1251 | 0.030 |
Why?
|
| Stilbenes | 1 | 2016 | 36 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 441 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2020 | 680 | 0.030 |
Why?
|
| Thermodynamics | 2 | 2007 | 144 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1711 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1243 | 0.030 |
Why?
|
| Genomics | 1 | 2020 | 1499 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2007 | 54 | 0.020 |
Why?
|
| Calorimetry | 1 | 2007 | 62 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2007 | 94 | 0.020 |
Why?
|
| Kv1.4 Potassium Channel | 1 | 2000 | 3 | 0.010 |
Why?
|
| Cholinergic Agonists | 1 | 2000 | 6 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 26927 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 184 | 0.010 |
Why?
|
| Allosteric Regulation | 1 | 2000 | 48 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 29628 | 0.010 |
Why?
|
| Muscles | 1 | 2000 | 292 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 296 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 772 | 0.010 |
Why?
|